Evidence map›Paper›PMID 30240421›Full record

ArticlePloS one2018

Activation of RHO-1 in cholinergic motor neurons competes with dopamine signalling to control locomotion.

Clara L Essmann, Katie R Ryan, Muna Elmi, Kimberley Bryon-Dodd, Andrew Porter, Andrew Vaughan, Rachel McMullan, Stephen Nurrish

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. The dopaminergic system ofRoyal Society open science · 2025
    Review
  2. Article
  3. A cGAL-UAS bipartite expression toolkit forProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Clara L EssmannMRC Laboratory for Molecular Cell Biology, University College London, London, United Kingdom.ORCID 0000-0001-5468-9489
Katie R RyanMRC Laboratory for Molecular Cell Biology, University College London, London, United Kingdom.ORCID 0000-0003-0488-5603
Muna ElmiMRC Laboratory for Molecular Cell Biology, University College London, London, United Kingdom.
Kimberley Bryon-DoddMRC Laboratory for Molecular Cell Biology, University College London, London, United Kingdom.
Andrew PorterMRC Laboratory for Molecular Cell Biology, University College London, London, United Kingdom.
Andrew VaughanMRC Laboratory for Molecular Cell Biology, University College London, London, United Kingdom.
Rachel McMullanMRC Laboratory for Molecular Cell Biology, University College London, London, United Kingdom.ORCID 0000-0003-2677-8016
Stephen NurrishMRC Laboratory for Molecular Cell Biology, University College London, London, United Kingdom.
MRC Laboratory for Molecular Cell Biology · GB

Funding

Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Ann E. Rougvie · 2012 to 2026
$7.5M
Medical Research Council MC_U122665003Medical Research Council MC_U122665004Medical Research Council MC_UU12018/8NIH HHS P40 OD010440
6 · The paper itself

Abstract

The small GTPase RhoA plays a crucial role in the regulation of neuronal signalling to generate behaviour. In the developing nervous system RhoA is known to regulate the actin cytoskeleton, however the effectors of RhoA-signalling in adult neurons remain largely unidentified. We have previously shown that activation of the RhoA ortholog (RHO-1) in C. elegans cholinergic motor neurons triggers hyperactivity of these neurons and loopy locomotion with exaggerated body bends. This is achieved in part through increased diacylglycerol (DAG) levels and the recruitment of the synaptic vesicle protein UNC-13 to synaptic release sites, however other pathways remain to be identified. Dopamine, which is negatively regulated by the dopamine re-uptake transporter (DAT), has a central role in modulating locomotion in both humans and C. elegans. In this study we identify a new pathway in which RHO-1 regulates locomotory behaviour by repressing dopamine signalling, via DAT-1, linking these two pathways together. We observed an upregulation of dat-1 expression when RHO-1 is activated and show that loss of DAT-1 inhibits the loopy locomotion phenotype caused by RHO-1 activation. Reducing dopamine signalling in dat-1 mutants through mutations in genes involved in dopamine synthesis or in the dopamine receptor DOP-1 restores the ability of RHO-1 to trigger loopy locomotion in dat-1 mutants. Taken together, we show that negative regulation of dopamine signalling via DAT-1 is necessary for the neuronal RHO-1 pathway to regulate locomotion.

Indexed as

LocomotionSignal TransductionAcetylcholineAnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsCholinergic NeuronsDopamineMotor NeuronsMutationNeuropeptidesPhenotyperho GTP-Binding ProteinsTranscription, GeneticUp-RegulationAcetylcholineCaenorhabditis elegans ProteinsDopamineNeuropeptidesRHO-1 protein, C elegansrho GTP-Binding Proteins

Identifiers

PMID30240421
PMCPMC6150489
OpenAlexW2889694429

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.